Literature DB >> 19604084

Relation between CYP2D6 genotype, personality, neurocognition and overall psychopathology in healthy volunteers.

Eva M Peñas-LLedó1, Pedro Dorado, Rodrigo Pacheco, Idilio González, Adrián LLerena.   

Abstract

AIMS: A lower serotonin/higher dopamine tone in CYP2D6 poor metabolizers (PMs) versus extensive metabolizers (EMs) has been postulated, which is consistent with our prior research showing behavioral traits related to anxiety and impulsivity in PMs. This tone could also be related to PMs vulnerability to cognitive functioning and/or psychopathology. Therefore, the present study aimed to analyze the relationship between CYP2D6 genotype and personality, cognition and psychopathological vulnerability. The influence of affective state in these relationships was also analyzed. MATERIALS &
METHODS: A total of 144 healthy volunteers from the University of Extremadura (Spain) were evaluated by CYP2D6 genotypes, overall psychopathology (Symptom Checklist-90-revised [SCL-90-R]), personality (Karolinska Scales of Personality [KSP] and Temperament and Character Inventory [TCI-R]) and on cognitive functions with computerized CANTAB tests.
RESULTS: PMs (n = 11) versus EMs (n = 133) (Mann-Whitney U-tests) presented higher 'impulsivity' in both KSP and TCI-R, and better performance of sustained attention (on the Rapid Visual Information Processing test) and lower overall psychopathology with all PMs scoring below 0.7 on SCL-90-R ('positive affect' group). There were differences between all participants scoring below (n = 107) and above (n = 37) 0.7 on SCL-90-R in most personality measures. Comparisons between PMs (n = 11) and EMs (n = 96) with SCL-90-R less than 0.7 maintained those results for KSP and CANTAB but also yielded greater scores on the TCI-R-'perfectionism' subscale in PMs. In multivariate analyses controlled for age, sex and psychopathology, KSP-impulsiveness, CANTAB-sustained attention, spatial working memory and paired associate learning were significantly different in PMs versus EMs.
CONCLUSION: In the studied population of healthy volunteers, PMs versus EMs showed lower vulnerability to psychopathology and greater impulsivity. Moreover, differences in neurocognition were found. The cross-study reproducibility of the relationship between CYP2D6 and personality may be difficult due to the influence of psychopathology among other factors. The personality and cognitive factors found in PMs appear compatible with a low serotonin/high dopamine balance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19604084     DOI: 10.2217/pgs.09.75

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  12 in total

Review 1.  CYP2D6 variation, behaviour and psychopathology: implications for pharmacogenomics-guided clinical trials.

Authors:  Eva M Peñas-Lledó; Adrián Llerena
Journal:  Br J Clin Pharmacol       Date:  2014-04       Impact factor: 4.335

Review 2.  Pharmacogenetic research activity in Central America and the Caribbean: a systematic review.

Authors:  Carolina Céspedes-Garro; María-Eugenia G Naranjo; Fernanda Rodrigues-Soares; Adrián LLerena; Jorge Duconge; Lazara K Montané-Jaime; Hilda Roblejo; Humberto Fariñas; María de Los A Campos; Ronald Ramírez; Víctor Serrano; Carmen I Villagrán; Eva M Peñas-LLedó
Journal:  Pharmacogenomics       Date:  2016-09-16       Impact factor: 2.533

3.  Ethanol self-administration and nicotine treatment increase brain levels of CYP2D in African green monkeys.

Authors:  R T Miller; S Miksys; E Hoffmann; R F Tyndale
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

4.  Novel drug metabolism indices for pharmacogenetic functional status based on combinatory genotyping of CYP2C9, CYP2C19 and CYP2D6 genes.

Authors:  David Villagra; John Goethe; Harold I Schwartz; Bonnie Szarek; Mohan Kocherla; Krystyna Gorowski; Andreas Windemuth; Gualberto Ruaño
Journal:  Biomark Med       Date:  2011-08       Impact factor: 2.851

Review 5.  Cytochrome P450 enzymes in the brain: emerging evidence of biological significance.

Authors:  Charmaine S Ferguson; Rachel F Tyndale
Journal:  Trends Pharmacol Sci       Date:  2011-10-03       Impact factor: 14.819

Review 6.  Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications.

Authors:  Natasha T Snider; Vyvyca J Walker; Paul F Hollenberg
Journal:  Pharmacol Rev       Date:  2010-02-04       Impact factor: 25.468

7.  Human CYP2D6 Is Functional in Brain In Vivo: Evidence from Humanized CYP2D6 Transgenic Mice.

Authors:  Cole Tolledo; Marlaina R Stocco; Sharon Miksys; Frank J Gonzalez; Rachel F Tyndale
Journal:  Mol Neurobiol       Date:  2020-03-18       Impact factor: 5.590

Review 8.  Pathophysiological implications of neurovascular P450 in brain disorders.

Authors:  Chaitali Ghosh; Mohammed Hossain; Jesal Solanki; Aaron Dadas; Nicola Marchi; Damir Janigro
Journal:  Drug Discov Today       Date:  2016-06-14       Impact factor: 7.851

9.  Severe psychosocial deprivation in early childhood is associated with increased DNA methylation across a region spanning the transcription start site of CYP2E1.

Authors:  R Kumsta; S J Marzi; J Viana; E L Dempster; B Crawford; M Rutter; J Mill; E J S Sonuga-Barke
Journal:  Transl Psychiatry       Date:  2016-06-07       Impact factor: 6.222

10.  Human CYP2D6 in the Brain Is Protective Against Harmine-Induced Neurotoxicity: Evidence from Humanized CYP2D6 Transgenic Mice.

Authors:  Marlaina R Stocco; Cole Tolledo; Fariba Baghai Wadji; Frank J Gonzalez; Sharon Miksys; Rachel F Tyndale
Journal:  Mol Neurobiol       Date:  2020-08-06       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.